发明授权
US09119843B2 Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
有权
使用多巴胺再摄取抑制剂及其类似物治疗糖尿病症状并延迟或预防糖尿病相关病理状况的方法
- 专利标题: Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
- 专利标题(中): 使用多巴胺再摄取抑制剂及其类似物治疗糖尿病症状并延迟或预防糖尿病相关病理状况的方法
-
申请号: US13509881申请日: 2010-12-03
-
公开(公告)号: US09119843B2公开(公告)日: 2015-09-01
- 发明人: Hao Chen , Ming Liu , Malathi Sathyamoorthy , Qi Su , Lisa Leary , Wayne Shaobin Zhong
- 申请人: Hao Chen , Ming Liu , Malathi Sathyamoorthy , Qi Su , Lisa Leary , Wayne Shaobin Zhong
- 申请人地址: US MA Hopkinton
- 专利权人: Caliper Life Sciences, Inc.
- 当前专利权人: Caliper Life Sciences, Inc.
- 当前专利权人地址: US MA Hopkinton
- 代理机构: Dann, Dorfman, Herrell and Skillman, P.C.
- 代理商 Thomas H. Walls
- 国际申请: PCT/US2010/058864 WO 20101203
- 国际公布: WO2011/069051 WO 20110609
- 主分类号: A61K31/4245
- IPC分类号: A61K31/4245 ; A61K45/00 ; A61K45/06
摘要:
Method of using dopamine reuptake inhibitors, e.g., sydnonimine derivatives, for the management of diabetic symptoms and associated complications or conditions, such as hyperglycemia and diabetic neuropathy.